Panacea Biotec Limited (PANACEABIO.NS)

INR 522.95

(5.0%)

Operating Expenses Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual operating expenses in 2023 was 1.99 Billion INR , down -42.06% from previous year.
Panacea Biotec Limited's latest quarterly operating expenses in 2024 Q1 was 504.9 Million INR , down -7.05% from previous quarter.
Panacea Biotec Limited reported a annual operating expenses of 3.44 Billion INR in annual operating expenses 2022, down -16.49% from previous year.
Panacea Biotec Limited reported a annual operating expenses of 4.12 Billion INR in annual operating expenses 2021, up 17.02% from previous year.
Panacea Biotec Limited reported a quarterly operating expenses of 1.99 Billion INR for 2023 FY, down -42.06% from previous quarter.
Panacea Biotec Limited reported a quarterly operating expenses of 941.2 Million INR for 2023 Q1, down -16.6% from previous quarter.

Annual Operating Expenses Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Operating Expenses of Panacea Biotec Limited (2023 - 2004)

Year	Operating Expenses	Operating Expenses Growth
2023	1.99 Billion INR	-42.06%
2022	3.44 Billion INR	-16.49%
2021	4.12 Billion INR	17.02%
2020	3.52 Billion INR	9.93%
2019	3.2 Billion INR	-9.55%
2018	3.54 Billion INR	5.02%
2017	3.37 Billion INR	5.72%
2016	3.19 Billion INR	-16.15%
2015	3.8 Billion INR	-4.64%
2014	3.99 Billion INR	-10.65%
2013	4.46 Billion INR	-12.75%
2012	5.12 Billion INR	26.37%
2011	4.05 Billion INR	-0.03%
2010	4.05 Billion INR	-49.0%
2009	7.94 Billion INR	-10.22%
2008	8.85 Billion INR	38.54%
2007	6.38 Billion INR	6.33%
2006	6 Billion INR	40.43%
2005	4.27 Billion INR	38.5%
2004	3.08 Billion INR	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	504.9 Million INR	-7.05%
2023 FY	1.99 Billion INR	-42.06%
2023 Q1	941.2 Million INR	-16.6%
2023 Q2	977 Million INR	3.8%
2023 Q3	456.8 Million INR	-53.24%
2023 Q4	543.2 Million INR	18.91%
2022 Q2	824 Million INR	-8.05%
2022 Q4	1.12 Billion INR	89.63%
2022 FY	3.44 Billion INR	-16.49%
2022 Q1	896.1 Million INR	30.29%
2022 Q3	595.1 Million INR	-27.78%
2021 Q4	687.79 Million INR	-36.3%
2021 FY	4.12 Billion INR	17.02%
2021 Q3	1.07 Billion INR	-18.92%
2021 Q1	1.02 Billion INR	22.99%
2021 Q2	1.33 Billion INR	30.01%
2020 FY	3.52 Billion INR	9.93%
2020 Q4	832.86 Million INR	-12.71%
2020 Q3	954.1 Million INR	4.17%
2020 Q2	915.9 Million INR	11.55%
2020 Q1	821.1 Million INR	104.5%
2019 Q2	1.05 Billion INR	22.97%
2019 Q3	893.5 Million INR	-15.2%
2019 Q4	401.52 Million INR	-55.06%
2019 FY	3.2 Billion INR	-9.55%
2019 Q1	856.9 Million INR	122.18%
2018 Q4	385.68 Million INR	-65.39%
2018 Q2	1 Billion INR	-3.86%
2018 Q1	1.04 Billion INR	0.0%
2018 FY	3.54 Billion INR	5.02%
2018 Q3	1.11 Billion INR	11.22%
2017 FY	3.37 Billion INR	5.72%
2016 FY	3.19 Billion INR	-16.15%
2015 FY	3.8 Billion INR	-4.64%
2014 FY	3.99 Billion INR	-10.65%
2013 FY	4.46 Billion INR	-12.75%
2012 FY	5.12 Billion INR	26.37%
2011 FY	4.05 Billion INR	-0.03%
2010 FY	4.05 Billion INR	-49.0%
2009 FY	7.94 Billion INR	-10.22%
2008 FY	8.85 Billion INR	38.54%
2007 FY	6.38 Billion INR	6.33%
2006 FY	6 Billion INR	40.43%
2005 FY	4.27 Billion INR	38.5%
2004 FY	3.08 Billion INR	0.0%

Peer Operating Expenses Comparison of Panacea Biotec Limited

Name	Operating Expenses	Operating Expenses Difference
Biocon Limited	40.9 Billion INR	95.122%
Blue Jet Healthcare Limited	531.85 Million INR	-275.181%
Concord Biotech Limited	1.45 Billion INR	-36.699%
Dishman Carbogen Amcis Limited	5.14 Billion INR	61.235%
Jubilant Ingrevia Limited	6.67 Billion INR	70.084%
Lyka Labs Limited	599.4 Million INR	-232.896%
Piramal Pharma Limited	19.91 Billion INR	89.98%
SMS Lifesciences India Limited	602.96 Million INR	-230.93%
Supriya Lifescience Limited	1.08 Billion INR	-84.734%
Syngene International Limited	5.99 Billion INR	66.716%
TAKE Solutions Limited	396.91 Million INR	-402.734%
Zota Health Care Limited	457.83 Million INR	-335.834%